Company: MVIS
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001641172-25-009765
Chunk: 123

Company: MICROVISION, INC.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 1
Chunk 123
---
8,754 
  
    Warrant liability 
     4,536  
     - 
  
    Operating lease liabilities, net of current portion 
     15,436  
     15,954 
  
    Finance lease liabilities, net of current portion 
     25  
     - 
  
    Other long-term liabilities 
     1,688  
     1,733 
  
    Total liabilities 
     63,539  
     72,392 

    Commitments and contingencies (Note 11) 
     -  
     - 

    Shareholders’ equity 

  Preferred stock, par value $0.001; 25,000 shares authorized; zero and
zero shares issued and outstanding

-

-

  Common stock, par value $0.001; 310,000 shares authorized;
245,440 and 224,993 shares issued and outstanding at March 31,
2025 and December 31, 2024, respectively

245

225

    Additional paid-in capital 
     943,900  
     910,825 
  
    Accumulated other comprehensive income 
     119  
     - 
  
    Accumulated deficit 
     (891,060) 
     (862,281)
  
    Total shareholders’ equity 
     53,204  
     48,769 
  
    Total liabilities and shareholders’ equity 
    $116,743  
    $121,161 

The
accompanying notes are an integral part of these financial statements.

3

MicroVision, Inc. 

Condensed
Consolidated Statements of Operations 

(In
thousands, except per share data)

(Unaudited)

    2025  
    2024 

    Three Months Ended 

    March 31, 

    2025  
    2024 

    Revenue 
    $589  
    $956 

    Cost of revenue 
     550  
     1,277 

    Gross profit (loss) 
     39  
     (321)

    Research and development expense 
     7,403  
     17,311 
  
    Sales, marketing, general and administrative expense 
     6,676  
     9,078 
  
    Total operating expenses 
     14,079  
     26,389 

    Loss from operations